UBS sets $28 Caris Life Sciences price target
UBS announced a $28.00/share price target for Caris Life Sciences.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.
UBS announced a $28.00/share price target for Caris Life Sciences.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.